FEIBA prophylaxis in a patient with haemophilia and inhibitors-Reference-Cited by-同舟云学术

FEIBA prophylaxis in a patient with haemophilia and inhibitors

Published:2014-10-01 Issue:3 Volume:1 Page:21-23
ISSN:2055-3390
Container-title:The Journal of Haemophilia Practice
language:en
Short-container-title:

Author:

Hook Susan¹

Affiliation:

1. Advanced Haemophilia and Thrombosis Nurse Specialist, Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, Little France Crescent, Edinburgh , UK EH16 4SA

Abstract

Abstract A case study is presented illustrating the everyday challenges faced by patients with haemophilia and inhibitors and how treatment with bypassing agents or just FEIBA prophylaxis can help to control bleeding and improve functional ability.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.17225/jhp.00031

Reference12 articles.

1. 1. Srivastava A, Brewer AK, MauserSBunschoten EP et al. Treatment Guidelines Working Group. The World Federation of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1V14.10.1111/j.1365-2516.2012.02909.x

2. 2. Hilgartner MW, Makipernaa A, DiMichele DM. LongSterm FEIBA prophylaxis does not prevent progression of existing joint disease. Haemophilia 2003; 9: 261V8.10.1046/j.1365-2516.2003.00771.x

3. 3. Valentino LA. FEIBA prophylaxis for patients with haemophilia and inhibitors. Haemophilia 2006; 12TSuppl. 5U: 26V31.10.1111/j.1365-2516.2006.01382.x

4. 4. Leissinger CA, Becton DL, Ewing NP, Valentino LA. Prophylactic treatment with activated prothrombin complex concentrate TFEIBA©U reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors. Haemophilia 2007; 13: 249V55.10.1111/j.1365-2516.2007.01442.x

5. 5. Leissinger C, Gringeri A, Antmen B et al. AntiSinhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Engl J Med 2011; 365: 1684V92.10.1056/NEJMoa1104435